BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Neuronal pentraxin II (NPTX2; NARP)

February 26, 2015 8:00 AM UTC

Mouse studies suggest inhibiting NPTX2 could help prevent levodopa-induced dyskinesia in PD patients (PD-LID). In a mouse model of PD-LID, up-regulation of NPTX2 in the striatum correlated with the se...